Skip to main content
Caplight Logo









Io Therapeutics, Inc.

Io Therapeutics, Inc.

Private
Spring, TexasHealthcare & Life Scienceshttps://io-therapeutics.com/

Last Round

VC Round

Mar 9, 2023

Total Funding Raised

$444,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Io Therapeutics, Inc. is a biopharmaceutical company that discovers and develops retinoid and rexinoid small molecule compounds for the treatment of cancer, neurodegenerative diseases, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverynuclear receptor modulatorssmall molecule therapeuticsoncologyimmunologypreclinical developmentbiotech startupautoimmune disease treatmentdrug pipelinebiopharmamedicinal chemistryretinoid therapeuticsrexinoid therapeuticstherapeutic licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Io Therapeutics, Inc. Comparables

Compare Io Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Io Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Iaterion, Inc.
86%
Orphagen Pharmaceuticals
85%
Regen BioPharma Inc
77%

Io Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 9, 2023
SeedJan 2, 2014

Key People

Founding team and executive leadership

Martin E. Sanders

Founder, Chairman, and Chief Executive Officer

Founding Team

Martin Sanders

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 80% MoM, from 1.4K to 2.5K.

  • Jul 27, 2026

    Monthly visitors increased 41% MoM, reaching 1.4K.

Io Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

Io Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Io Therapeutics, Inc.'s valuation, stock price, and market status.

Is Io Therapeutics, Inc. a public or private company?

Io Therapeutics, Inc. is a private company.

What is the current stock price of Io Therapeutics, Inc.?

Io Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Io Therapeutics, Inc. worth (valuation)?

Valuation information for Io Therapeutics, Inc. is not publicly available.

Can I buy Io Therapeutics, Inc. stock?

Io Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Io Therapeutics, Inc.'s last funding round?

Io Therapeutics, Inc.'s most recent funding round was VC Round on March 9, 2023.

Who are the main investors in Io Therapeutics, Inc.?

Investor information for Io Therapeutics, Inc. is not publicly disclosed.

Will Io Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for Io Therapeutics, Inc..

How can I track Io Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Io Therapeutics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpring, Texas
Employee Range2
Year Founded2011
Last FundingMar 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?